
AML.L vs STLA

In the past 12 months, AML.L returned -42% while STLA lost 57%.
Valuation
Compare price multiples and valuation ratios
| Metric | AML.L | STLA | Winner |
|---|---|---|---|
P/E Ratio Price to earnings ratio | -0.60 | -0.59 | AML.L |
Forward P/E Forward price to earnings ratio | 0.00 | 0.00 | Tie |
P/S Ratio Price to sales ratio | 0.22 | 0.07 | STLA |
P/B Ratio Price to book ratio | 2.11 | 0.19 | STLA |
P/FCF Ratio Price to free cash flow ratio | -1.49 | -1.45 | AML.L |
EV/EBITDA Enterprise value to EBITDA | 7.44 | -1.74 | STLA |
PEG Ratio Price/earnings to growth ratio | 0.00 | 0.00 | Tie |
Profitability
Compare profit margins and returns on capital
| Metric | AML.L | STLA | Winner |
|---|---|---|---|
Gross Margin Gross profit margin | 18.5% | 0.9% | AML.L |
Operating Margin Operating profit margin | -13.3% | -12.0% | STLA |
Net Margin Net profit margin | -36.7% | -12.1% | STLA |
ROE Return on equity | -166.6% | -33.8% | STLA |
ROA Return on assets | -23.7% | -9.1% | STLA |
ROIC Return on invested capital | -11.5% | -10.9% | STLA |
Growth
Compare revenue and earnings growth rates
| Metric | AML.L | STLA | Winner |
|---|---|---|---|
Revenue Growth (YoY) Year-over-year revenue growth | -20.6% | -2.1% | STLA |
Revenue Growth (3Y) 3-year revenue CAGR | -3.1% | -5.1% | AML.L |
Revenue Growth (5Y) 5-year revenue CAGR | 15.5% | 26.4% | STLA |
EPS Growth (YoY) Year-over-year EPS growth | -28.2% | -521.2% | AML.L |
EPS Growth (3Y) 3-year EPS CAGR | 0.0% | 0.0% | Tie |
EPS Growth (5Y) 5-year EPS CAGR | 0.0% | 0.0% | Tie |
Balance Sheet & Risk
Compare financial stability and debt levels
| Metric | AML.L | STLA | Winner |
|---|---|---|---|
Debt/Equity Debt to equity ratio | 8.94 | 0.85 | STLA |
Current Ratio Current assets to current liabilities | 0.93 | 1.04 | STLA |
Quick Ratio Quick assets to current liabilities | 0.49 | 0.76 | STLA |
Interest Coverage EBIT to interest expense | -1.43 | -16.69 | AML.L |
Beta Stock volatility vs market | 1.94 | 0.99 | STLA |
7222.T
PSNY
LOT